Your browser doesn't support javascript.
loading
Maternal and perinatal health research during emerging and ongoing epidemic threats: a landscape analysis and expert consultation.
Bonet, Mercedes; Babinska, Magdalena; Buekens, Pierre; Goudar, Shivaprasad S; Kampmann, Beate; Knight, Marian; Meaney-Delman, Dana; Lamprianou, Smaragda; Rivas, Flor Muñoz; Stergachis, Andy; Toscano, Cristiana M; Bhatia, Joycelyn; Chamberlain, Sarah; Chaudhry, Usman; Mills, Jacqueline; Serazin, Emily; Short, Hannah; Steene, Asher; Wahlen, Michael; Oladapo, Olufemi T.
Afiliação
  • Bonet M; UNDP/UNFPA/UNICEF/WHO/World Bank Special Programme of Research, Development and Research Training in Human Reproduction (HRP), Department of Sexual and Reproductive Health and Research, World Health Organization, Geneva, Switzerland bonetm@who.int.
  • Babinska M; UNDP/UNFPA/UNICEF/WHO/World Bank Special Programme of Research, Development and Research Training in Human Reproduction (HRP), Department of Sexual and Reproductive Health and Research, World Health Organization, Geneva, Switzerland.
  • Buekens P; Department of Epidemiology, Tulane School of Public Health and Tropical Medicine, New Orleans, Louisiana, USA.
  • Goudar SS; Women's and Children's Health Research Unit, KLE Academy of Higher Education and Research's, Jawaharlal Nehru Medical College, Belgaum, Karnataka, India.
  • Kampmann B; Charité Centre for Global Health, Universitätsmedizin Charité Berlin, Berlin, Germany.
  • Knight M; National Perinatal Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.
  • Meaney-Delman D; Division of Birth Defects and Infant Disorders, National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • Lamprianou S; Pharmacovigilance Team, Regulation and Prequalification Department, Access to Medicines and Health Products Division, World Health Organization, Geneva, Switzerland.
  • Rivas FM; Departments of Pediatrics and Molecular Virology & Microbiology, Baylor College of Medicine, and Texas Children's Hospital, Houston, Texas, USA.
  • Stergachis A; School of Pharmacy and School of Public Health, University of Washington, Seattle, Washington, USA.
  • Toscano CM; Institute of Tropical Pathology and Public Health, Federal University of Goias, Goiania, Brazil.
  • Bhatia J; Boston Consulting Group, London, UK.
  • Chamberlain S; Boston Consulting Group, London, UK.
  • Chaudhry U; Boston Consulting Group, London, UK.
  • Mills J; Boston Consulting Group, London, UK.
  • Serazin E; Boston Consulting Group, London, UK.
  • Short H; Boston Consulting Group, London, UK.
  • Steene A; Boston Consulting Group, London, UK.
  • Wahlen M; Boston Consulting Group, London, UK.
  • Oladapo OT; UNDP/UNFPA/UNICEF/WHO/World Bank Special Programme of Research, Development and Research Training in Human Reproduction (HRP), Department of Sexual and Reproductive Health and Research, World Health Organization, Geneva, Switzerland.
BMJ Glob Health ; 9(3)2024 Mar 07.
Article em En | MEDLINE | ID: mdl-38453249
ABSTRACT

INTRODUCTION:

Pregnant women and their offspring are often at increased direct and indirect risks of adverse outcomes during epidemics and pandemics. A coordinated research response is paramount to ensure that this group is offered at least the same level of disease prevention, diagnosis, and care as the general population. We conducted a landscape analysis and held expert consultations to identify research efforts relevant to pregnant women affected by disease outbreaks, highlight gaps and challenges, and propose solutions to addressing them in a coordinated manner.

METHODS:

Literature searches were conducted from 1 January 2015 to 22 March 2022 using Web of Science, Google Scholar and PubMed augmented by key informant interviews. Findings were reviewed and Quid analysis was performed to identify clusters and connectors across research networks followed by two expert consultations. These formed the basis for the development of an operational framework for maternal and perinatal research during epidemics.

RESULTS:

Ninety-four relevant research efforts were identified. Although well suited to generating epidemiological data, the entire infrastructure to support a robust research response remains insufficient, particularly for use of medical products in pregnancy. Limitations in global governance, coordination, funding and data-gathering systems have slowed down research responses.

CONCLUSION:

Leveraging current research efforts while engaging multinational and regional networks may be the most effective way to scale up maternal and perinatal research preparedness and response. The findings of this landscape analysis and proposed operational framework will pave the way for developing a roadmap to guide coordination efforts, facilitate collaboration and ultimately promote rapid access to countermeasures and clinical care for pregnant women and their offspring in future epidemics.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Atenção à Saúde / Pandemias Limite: Female / Humans / Pregnancy Idioma: En Revista: BMJ Glob Health Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Suíça

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Atenção à Saúde / Pandemias Limite: Female / Humans / Pregnancy Idioma: En Revista: BMJ Glob Health Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Suíça